These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 17506681)

  • 1. Lantibiotics: peptides of diverse structure and function.
    Willey JM; van der Donk WA
    Annu Rev Microbiol; 2007; 61():477-501. PubMed ID: 17506681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple activities in lantibiotics--models for the design of novel antibiotics?
    Pag U; Sahl HG
    Curr Pharm Des; 2002; 8(9):815-33. PubMed ID: 11945173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lantibiotics: insight and foresight for new paradigm.
    Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodologies and strategies for the bioengineering of lantibiotics.
    Nagao J; Nishie M; Sonomot K
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1221-30. PubMed ID: 21470152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of subtilin and nisin biosyntheses: biosynthesis of lantibiotics.
    Entian KD; de Vos WM
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):109-17. PubMed ID: 8775971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.
    McClerren AL; Cooper LE; Quan C; Thomas PM; Kelleher NL; van der Donk WA
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17243-8. PubMed ID: 17085596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights.
    Goto Y; Li B; Claesen J; Shi Y; Bibb MJ; van der Donk WA
    PLoS Biol; 2010 Mar; 8(3):e1000339. PubMed ID: 20351769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lantibiotics: mode of action, biosynthesis and bioengineering.
    Bierbaum G; Sahl HG
    Curr Pharm Biotechnol; 2009 Jan; 10(1):2-18. PubMed ID: 19149587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 21. In vitro studies of lantibiotic biosynthesis.
    Li B; Cooper LE; van der Donk WA
    Methods Enzymol; 2009; 458():533-58. PubMed ID: 19374997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognizing and Predicting Thioether Bridges Formed by Lanthionine and β-Methyllanthionine in Lantibiotics Using a Random Forest Approach with Feature Selection.
    Wang S; Zhang YH; Zhang N; Chen L; Huang T; Cai YD
    Comb Chem High Throughput Screen; 2017; 20(7):582-593. PubMed ID: 28294058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides.
    Claesen J; Bibb M
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16297-302. PubMed ID: 20805503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid supported chemical syntheses of both components of the lantibiotic lacticin 3147.
    Liu W; Chan AS; Liu H; Cochrane SA; Vederas JC
    J Am Chem Soc; 2011 Sep; 133(36):14216-9. PubMed ID: 21848315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase.
    Krawczyk B; Völler GH; Völler J; Ensle P; Süssmuth RD
    Chembiochem; 2012 Sep; 13(14):2065-71. PubMed ID: 22907786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lantibiotics: promising candidates for future applications in health care.
    Dischinger J; Basi Chipalu S; Bierbaum G
    Int J Med Microbiol; 2014 Jan; 304(1):51-62. PubMed ID: 24210177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
    Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
    Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.
    Repka LM; Chekan JR; Nair SK; van der Donk WA
    Chem Rev; 2017 Apr; 117(8):5457-5520. PubMed ID: 28135077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5.
    Bierbaum G; Szekat C; Josten M; Heidrich C; Kempter C; Jung G; Sahl HG
    Appl Environ Microbiol; 1996 Feb; 62(2):385-92. PubMed ID: 8593044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics synthesized by posttranslational modification.
    Hansen JN
    Annu Rev Microbiol; 1993; 47():535-64. PubMed ID: 8257108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Analysis of Class I Lanthipeptides from
    Bothwell IR; Caetano T; Sarksian R; Mendo S; van der Donk WA
    ACS Chem Biol; 2021 Jun; 16(6):1019-1029. PubMed ID: 34085816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.